Calls for papers

Highlight your research and enhance its visibility to your field and community by submitting to one of our Collections. Collections at npj Precision Oncology provide a high-profile venue for topics of substantial interest to the community. Papers included in a Collection are published in the journal and featured on our Collection page.

  • Genomic Instability

    Reconstructing DNA molecular structure by network
      Collection
      Submission status: Open Deadline: 24 March 2026

    • AI agents in oncology

      This Collection explores AI agents in oncology, including autonomous and multimodal systems for clinical decision-making, workflow automation, reasoning and their trustworthiness.
        Collection
        Submission status: Open Deadline: 20 February 2026

      • Epitranscriptomics and RNA structure in cancer

        This collection examines how RNA modifications and structures shape cancer biology, emphasizing molecular mechanisms, emerging technologies, and therapeutic prospects.
          Collection
          Submission status: Open Deadline: 20 February 2026

        • Artificial intelligence biomarkers in precision oncology

          In this Collection, we will explore the development, clinical applications, and future potential of AI-based biomarkers in oncology, highlighting how they may complement or even surpass traditional molecular diagnostics.
            Collection
            Submission status: Open Deadline: 24 November 2025

          • Tumor-type-agnostic biomarkers and treatments in oncology

            This Collection invites contributions of cutting-edge research and comprehensive reviews focusing on biomarkers and treatment strategies within the transformative tumor-agnostic framework of oncology. Research on challenges to the implementation of tumor-type-agnostic therapies as well as socio-economic impact analysis will also be considered.
              Collection
              Submission status: Open Deadline: 05 September 2025

            • AI Approaches in Drug Design

              Inviting research on AI-driven methods in drug design, from target identification to lead optimisation, enhancing precision oncology, and combating resistance.
                Collection
                Submission status: Open Deadline: 18 August 2025

              • Antibody-drug conjugates for solid tumors

                Antibody drug conjugates (ADCs) have revolutionized the field of oncology with more than 100 ADCs in clinical development for different solid tumors. In this series, we will comprehensively review the clinical development of ADCs in different solid tumors, and how ADCs are replacing traditional chemotherapy in oncology.
                  Collection
                  Submission status: Open Deadline: 15 October 2025

                • Cell-free DNA epigenomics for early cancer and MRD detection

                  This Collection invites cell-free DNA research focusing on early cancer and minimal residual disease detection that centers on epigenomic features (i.e. methylation, fragmentomics).
                    Collection
                    Submission status: Open Deadline: 14 October 2025